|
1
|
Moffat DA and Ballagh RH: Rare tumours of
the cerebellopontine angle. Clin Oncol (R Coll Radiol). 7:28–41.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neff BA, Welling DB, Akhmametyeva E and
Chang LS: The molecular biology of vestibular schwannomas:
Dissecting the pathogenic process at the molecular level. Otol
Neurotol. 27:197–208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marinelli JP, Grossardt BR, Lohse CM and
Carlson ML: Prevalence of sporadic vestibular schwannoma:
Reconciling temporal bone, radiologic, and population-based
studies. Otol Neurotol. 40:384–390. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Evans DG, Howard E, Giblin C, Clancy T,
Spencer H, Huson SM and Lalloo F: Birth incidence and prevalence of
tumor-prone syndromes: Estimates from a UK family genetic register
service. Am J Med Genet A. 152A:327–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan SA, Marinelli JP, Hahs-Vaughn DL, Nye
C, Link MJ and Carlson ML: Evolution in management trends of
sporadic vestibular schwannoma in the United States over the last
half-century. Otol Neurotol. 42:300–305. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Macielak RJ, Driscoll CLW, Link MJ, Haynes
DS, Lohse CM and Carlson ML: Vestibular schwannoma practice
patterns: An International cross-specialty survey. Otol Neurotol.
41:e1304–e1313. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trofatter JA, MacCollin MM, Rutter JL,
Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG,
Pulaski K, et al: A novel moesin-, ezrin-, radixin-like gene is a
candidate for the neurofibromatosis 2 tumor suppressor. Cell.
75:8261993.PubMed/NCBI
|
|
8
|
Rouleau GA, Merel P, Lutchman M, Sanson M,
Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C,
Plougastel B, et al: Alteration in a new gene encoding a putative
membrane-organizing protein causes neuro-fibromatosis type 2.
Nature. 363:515–521. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Vries M, van der Mey AG and Hogendoorn
PC: Tumor biology of vestibular schwannoma: A review of
experimental data on the determinants of tumor genesis and growth
characteristics. Otol Neurotol. 36:1128–1136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tamura R and Toda M: A critical overview
of targeted therapies for vestibular schwannoma. Int J Mol Sci.
23:54622022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goshtasbi K, Abouzari M, Moshtaghi O,
Sahyouni R, Sajjadi A, Lin HW and Djalilian HR: The changing
landscape of vestibular schwannoma diagnosis and management: A
cross-sectional study. Laryngoscope. 130:482–486. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nadol JB Jr, Diamond PF and Thornton AR:
Correlation of hearing loss and radiologic dimensions of vestibular
schwannomas (acoustic Neuromas). Am J Otol. 17:312–316.
1996.PubMed/NCBI
|
|
13
|
Roosli C, Linthicum FH Jr, Cureoglu S and
Merchant SN: Dysfunction of the cochlea contributing to hearing
loss in acoustic neuromas: An underappreciated entity. Otol
Neurotol. 33:473–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lassaletta L, Calvino M, Morales-Puebla
JM, Lapunzina P, Rodriguez-de la Rosa L, Varela-Nieto I and
Martinez-Glez V: Biomarkers in vestibular schwannoma-associated
hearing loss. Front Neurol. 10:9782019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fujita T, Saito K, Kashiwagi N, Sato M,
Seo T and Doi K: The prevalence of vestibular schwannoma among
patients treated as sudden sensorineural hearing loss. Auris Nasus
Larynx. 46:78–82. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kiyofuji S, Neff BA, Carlson ML, Driscoll
CLW and Link MJ: Large and small vestibular schwannomas: Same, yet
different tumors. Acta Neurochir (Wien). 163:2199–2207. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koos WT, Day JD, Matula C and Levy DI:
Neurotopographic considerations in the microsurgical treatment of
small acoustic neurinomas. J Neurosurg. 88:506–512. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar P, Henikoff S and Ng PC: Predicting
the effects of coding non-synonymous variants on protein function
using the SIFT algorithm. Nat Protoc. 4:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rogers MF, Shihab HA, Mort M, Cooper DN,
Gaunt TR and Campbell C: FATHMM-XF: Accurate prediction of
pathogenic point mutations via extended features. Bioinformatics.
34:511–513. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rogers MF, Shihab HA, Gaunt TR and
Campbell C: CScape: A tool for predicting oncogenic single-point
mutations in the cancer genome. Sci Rep. 7:115972017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Galuppini F, Dal Pozzo CA, Deckert J,
Loupakis F, Fassan M and Baffa R: Tumor mutation burden: From
comprehensive mutational screening to the clinic. Cancer Cell Int.
19:2092019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Antinheimo J, Sallinen SL, Sallinen P,
Haapasalo H, Helin H, Horelli-Kuitunen N, Wessman M, Sainio M,
Jääskeläinen J and Carpén O: Genetic aberrations in sporadic and
neurofibromatosis 2 (NF2)-associated schwannomas studied by
comparative genomic hybridization (CGH). Acta Neurochir (Wien).
142:1099–1104; discussion 1104-5. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Welling DB, Lasak JM, Akhmametyeva E,
Ghaheri B and Chang LS: cDNA microarray analysis of vestibular
schwannomas. Otol Neurotol. 23:736–748. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ikeda T, Hashimoto S, Fukushige S, Ohmori
H and Horii A: Comparative genomic hybridization and mutation
analyses of sporadic schwannomas. J Neurooncol. 72:225–230. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bian LG, Tirakotai W, Sun QF, Zhao WG,
Shen JK and Luo QZ: Molecular genetics alterations and tumor
behavior of sporadic vestibular schwannoma from the People's
Republic of China. J Neurooncol. 73:253–260. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hadfield KD, Smith MJ, Urquhart JE,
Wallace AJ, Bowers NL, King AT, Trump D, Newman WG and Evans DG:
Rates of loss of heterozygosity and mitotic recombination in NF2
schwannomas, sporadic vestibular schwannomas and schwannomatosis
schwannomas. Oncogene. 29:6216–6221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aarhus M, Bruland O, Saetran HA, Mork SJ,
Lund-Johansen M and Knappskog PM: Global gene expression profiling
and tissue microarray reveal novel candidate genes and
down-regulation of the tumor suppressor gene CAV1 in sporadic
vestibular schwannomas. Neurosurgery. 67:998–1019. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JD, Kwon TJ, Kim UK and Lee WS:
Genetic and epigenetic alterations of the NF2 gene in sporadic
vestibular schwannomas. PLoS One. 7:e304182012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lassaletta L, Torres-Martin M,
Pena-Granero C, Roda JM, Santa-Cruz-Ruiz S, Castresana JS, Gavilan
J and Rey JA: NF2 genetic alterations in sporadic vestibular
schwannomas: Clinical implications. Otol Neurotol. 34:1355–1361.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Torres-Martin M, Lassaletta L,
San-Roman-Montero J, De Campos JM, Isla A, Gavilan J, Melendez B,
Pinto GR, Burbano RR, Castresana JS and Rey JA: Microarray analysis
of gene expression in vestibular schwannomas reveals SPP1/MET
signaling pathway and androgen receptor deregulation. Int J Oncol.
42:848–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agnihotri S, Jalali S, Wilson MR, Danesh
A, Li M, Klironomos G, Krieger JR, Mansouri A, Khan O, Mamatjan Y,
et al: The genomic landscape of schwannoma. Nat Genet.
48:1339–1348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Havik AL, Bruland O, Myrseth E, Miletic H,
Aarhus M, Knappskog PM and Lund-Johansen M: Genetic landscape of
sporadic vestibular schwannoma. J Neurosurg. 128:911–922. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen H, Xue L, Wang H, Wang Z and Wu H:
Differential NF2 gene status in sporadic vestibular schwannomas and
its prognostic impact on tumour growth patterns. Sci Rep.
7:54702017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Carlson ML, Smadbeck JB, Link MJ, Klee EW,
Vasmatzis G and Schimmenti LA: Next generation sequencing of
sporadic vestibular schwannoma: Necessity of Biallelic NF2
inactivation and implications of accessory Non-NF2 Variants. Otol
Neurotol. 39:e860–e871. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Puckelwartz MJ, Kessler E, Zhang Y, Hodzic
D, Randles KN, Morris G, Earley JU, Hadhazy M, Holaska JM, Mewborn
SK, et al: Disruption of nesprin-1 produces an Emery Dreifuss
muscular dystrophy-like phenotype in mice. Hum Mol Genet.
18:607–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gama MTD, Braga-Neto P, Dutra LA, Alessi
H, Maria LA, Gadelha AA, Ortiz BB, Kunii I, Correia-Silva SR, Dias
da Silva MR, et al: Cognitive and psychiatric evaluation in SYNE1
Ataxia. Cerebellum. 18:731–737. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Xiao X, Bosse Y, Gorlova O, Gorlov
I, Han Y, Byun J, Leighl N, Johansen JS, Barnett M, et al: Genetic
interaction analysis among oncogenesis-related genes revealed novel
genes and networks in lung cancer development. Oncotarget.
10:1760–1774. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shah K, Patel S, Modi B, Shah F and Rawal
R: Uncovering the potential of CD44v/SYNE1/miR34a axis in salivary
fluids of oral cancer patients. J Oral Pathol Med. 47:345–352.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Faraj Shaglouf LH, Ranjpour M, Wajid S and
Jain SK: Elevated expression of cellular SYNE1, MMP10, and GTPase1
and their regulatory role in hepatocellular carcinoma progression.
Protoplasma. 257:157–167. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shaw LM: The insulin receptor substrate
(IRS) proteins: At the intersection of metabolism and cancer. Cell
Cycle. 10:1750–1756. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
AACR Project GENIE Consortium, . AACR
Project GENIE: Powering precision medicine through an International
consortium. Cancer Discov. 7:818–831. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee Y: Regulation and function of capicua
in mammals. Exp Mol Med. 52:531–537. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pacifici M: Hereditary multiple exostoses:
New Insights into pathogenesis, clinical complications, and
potential treatments. Curr Osteoporos Rep. 15:142–152. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hobbs GA, Der CJ and Rossman KL: RAS
isoforms and mutations in cancer at a glance. J Cell Sci.
129:1287–1292. 2016.PubMed/NCBI
|
|
46
|
Lennon MJ, Jones SP, Lovelace MD,
Guillemin GJ and Brew BJ: Bcl11b-A critical neurodevelopmental
transcription factor-roles in health and disease. Front Cell
Neurosci. 11:892017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nakagaki T, Tamura M, Kobashi K, Koyama R,
Fukushima H, Ohashi T, Idogawa M, Ogi K, Hiratsuka H, Tokino T and
Sasaki Y: Profiling cancer-related gene mutations in oral squamous
cell carcinoma from Japanese patients by targeted amplicon
sequencing. Oncotarget. 8:59113–59122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Oh HR, An CH, Yoo NJ and Lee SH:
Frameshift mutations in the mononucleotide repeats of TAF1 and
TAF1L genes in gastric and colorectal cancers with regional
heterogeneity. Pathol Oncol Res. 23:125–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Aaron KA, Manojlovic Z, Tu N, Xu Y, Jin Y,
Chang S, Kwok E, Webb M, Hurth K and Friedman RA: What genes can
tell: A closer look at vestibular schwannoma. Otol Neurotol.
41:522–529. 2020. View Article : Google Scholar : PubMed/NCBI
|
